Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 5 years by 9.35% on an annualized basis.
Buying $1,000 In VRTX: 5 years ago, an investor could have purchased 10.95 shares of Vertex Pharmaceuticals at the time with $1,000. This investment in VRTX would have produced an average annual return of 22.8%. Currently, Vertex Pharmaceuticals has a market capitalization of $63.67 billion.
